3
Announcements
Trials
Browse
Landscape
Sponsor
Conditions
Squamous Cell Carcinoma of Head and Neck
12
Oropharyngeal Neoplasms
11
Lung Neoplasms
8
Laryngeal Neoplasms
8
Carcinoma
8
Mouth Neoplasms
7
Carcinoma, Non-Small-Cell Lung
7
Hypopharyngeal Neoplasms
6
Nasopharyngeal Carcinoma
5
Mesothelioma, Malignant
5
Urinary Bladder Neoplasms
4
Pancreatic Neoplasms
4
Uterine Cervical Neoplasms
3
Lymphoid Interstitial Pneumonia
3
Gallbladder Neoplasms
3
Triple Negative Breast Neoplasms
2
Salivary Gland Neoplasms
2
Paranasal Sinus Neoplasms
2
Ovarian Neoplasms
2
Medulloblastoma
2
Ganglioneuroblastoma
2
Cholangiocarcinoma
2
Adenocarcinoma of Lung
2
Vulvar Neoplasms
1
Vaginal Neoplasms
1
Tongue Neoplasms
1
Testicular Neoplasms
1
Teratoma
1
Stomatitis
1
Stage III Nasal Cavity and Paranasal Sinus Squamous Cell Carcinoma AJCC v6 and v7
1
Interventions
Specimen Handling
5
Nivolumab
5
Magnetic Resonance Spectroscopy
4
cabozantinib
3
Ipilimumab
3
Gemcitabine
3
CTLA-4 Antigen
3
enfortumab vedotin
2
avelumab
2
Immunoglobulin G
2
Disulfides
2
Carboplatin
2
Biopsy
2
tremelimumab
1
trastuzumab deruxtecan
1
tocilizumab
1
relatlimab
1
pembrolizumab
1
eribulin
1
erdafitinib
1
durvalumab
1
atezolizumab
1
Lenalidomide
1
Doxorubicin
1
Contrast Media
1
Cisplatin
1
Bortezomib
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
0 trials
Recent
Start date
Enrollment
Urethral Neoplasms
×
1,2-diaminocyclohexaneplatinum II citrate
×
90 days
×
Clear all
No trials found.